Nongonococcal Urethritis Pathogens and Diagnostic Approaches

Nongonococcal urethritis (NGU) is a common sexually transmitted syndrome characterised by urethral inflammation not attributable to Neisseria gonorrhoeae. Principal aetiological agents include Chlamydia trachomatis and Mycoplasma genitalium, while others such as Ureaplasma urealyticum, Trichomonas vaginalis and emerging organisms like Mycoplasma penetrans contribute to a substantial diagnostic gap. Up to 35% of cases remain idiopathic, reflecting limitations in conventional culture and microscopy methods. Advances in molecular diagnostics have shifted the paradigm towards nucleic acid amplification tests (NAATs), which offer enhanced sensitivity and specificity. Multiplex approaches now permit simultaneous detection of multiple targets, reducing turnaround time and informing tailored therapy. Rapid lateral flow assays and microarray platforms further facilitate point-of-care screening and genotyping, addressing challenges of co-infection and antimicrobial resistance. Global efforts emphasise integration of these tools into public health programmes to curb transmission, improve partner management and guide empirical treatment strategies across diverse healthcare settings.

Research from Nature Portfolio

A comprehensive evaluation of a novel microarray-based assay demonstrated the capacity to detect eight obligate or facultative NGU pathogens with high specificity and broad coverage. In a retrospective analysis of over 300 clinical specimens, the assay reliably identified Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma species, herpes simplex viruses and others, with specificities approaching 100% for most targets. Importantly, polymicrobial infections were detected in nearly half of positive cases, underscoring the prevalence of co-infections. While sensitivity was marginally lower for certain targets, the platform’s ability to survey a wide pathogen spectrum in a single workflow positions it as a valuable tool for surveillance and routine diagnostics, particularly in settings where under-recognised organisms may escape standard testing panels.

Nongonococcal Urethritis Pathogens and Diagnostic Approaches publication trend

The graph below shows the total number of articles in nongonococcal urethritis pathogens and diagnostic approaches across all publications each year (not limited to Nature Index journals).

Technical terms

Nongonococcal urethritis (NGU): Inflammation of the urethra caused by pathogens other than Neisseria gonorrhoeae, typically presenting with urethral discharge, dysuria or asymptomatic leukocyturia.

Nucleic acid amplification test (NAAT): A molecular method that amplifies specific DNA or RNA sequences of pathogens to achieve high analytical sensitivity and specificity.

Multiplex PCR: A polymerase chain reaction technique that simultaneously amplifies multiple target sequences in a single reaction, enabling rapid detection of diverse pathogens.

Lateral flow strip assay: A point-of-care diagnostic device that uses capillary action to move amplified nucleic acids across a membrane where they hybridise to specific probes, producing a visual read-out.

Polymicrobial infection: Concurrent infection by two or more microbial species in the same anatomical site, often complicating diagnosis and treatment choices.

References

1. Development of a DNA-Based Lateral Flow Strip Membrane Assay for Rapid Screening and Genotyping of Six High-Incidence STD Pathogens. Biosensors (2024).
2. Mycoplasma penetrans urethritis in men. A case–control study. Frontiers in Microbiology (2025).
3. A retrospective evaluation of the Euroarray STI-11 multiplex system for the detection of eight STI causing agents. Scientific Reports (2023).
4. Comparison of analytical sensitivity of DNA-based and RNA-based nucleic acid amplification tests for reproductive tract infection pathogens: implications for clinical applications. Microbiology Spectrum (2023).